We are live on ! Find out more
ABBV icon

AbbVie
ABBV

2,655 hedge funds and large institutions have $127B invested in AbbVie in 2021 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 1,346 increasing their positions, 872 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 1,346 | Existing positions reduced: 872

21% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 97

0.36% less ownership

Funds ownership: 67.05% → 66.69% (-0.36%)

1% less funds holding

Funds holding: 2,677 → 2,655 (-22)

1% less call options, than puts

Call options by funds: $2.19B | Put options by funds: $2.22B

5% less capital invested

Capital invested by funds: $133B → $127B (-$6.15B)

4% less funds holding in top 10

Funds holding in top 10: 139 → 134 (-5)

Holders
2,655
Holders Change
-22
Holders Change %
-0.82%
% of All Funds
46.47%
Holding in Top 10
134
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-3.6%
% of All Funds
2.35%
New
117
Increased
1,346
Reduced
872
Closed
97
Calls
$2.19B
Puts
$2.22B
Net Calls
-$32.5M
Net Calls Change
+$47.7M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$1.02B
2
BlackRock
BlackRock
New York
+$485M
3
Goldman Sachs
Goldman Sachs
New York
+$346M
4
Ameriprise
Ameriprise
Minnesota
+$325M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$278M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.58B
2
Berkshire Hathaway
Berkshire Hathaway
Nebraska
-$700M
3
OAG
Orbis Allan Gray
Bermuda
-$414M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$319M
5
Winslow Capital Management
Winslow Capital Management
Minnesota
-$268M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCFD
1126
Boit C.F. David
$2.76M – – –
HSA
1127
HBK Sorce Advisory
Pennsylvania
$2.76M +$199K +1,745 +7%
NPA
1128
Nichols & Pratt Advisers
Massachusetts
$2.76M +$229K +2,005 +9%
BFM
1129
Boston Financial Management
Massachusetts
$2.75M +$64.7K +566 +2%
MCA
1130
Morris Capital Advisors
Pennsylvania
$2.75M -$122K -1,065 -4%
PDN
1131
Pensionfund DSM Netherlands
Netherlands
$2.74M -$3.22M -28,200 -53%
FCM
1132
Fortis Capital Management
Washington
$2.73M +$2.27M +19,846 +360%
BL
1133
BFSG LLC
California
$2.73M +$57K +499 +2%
LFF
1134
Level Four Financial
Texas
$2.73M +$85K +744 +3%
HFM
1135
Hartford Financial Management
Connecticut
$2.71M +$11.1K +97 +0.4%
GCM
1136
Glynn Capital Management
California
$2.7M – – –
HCA
1137
Horan Capital Advisors
Ohio
$2.7M +$69.9K +612 +3%
AMC
1138
Asset Management Corp
Illinois
$2.69M +$543K +4,750 +23%
TI
1139
Truehand Inc
New Hampshire
$2.69M – – –
F
1140
F3Logic
Minnesota
$2.69M +$61.5K +538 +2%
PM
1141
Prosight Management
Texas
$2.67M +$2.83M +24,800 New
HHAA
1142
Henry H. Armstrong Associates
Pennsylvania
$2.67M +$68.6K +600 +2%
GI
1143
GAMCO Investors
Connecticut
$2.67M +$357K +3,122 +14%
CWA
1144
Clarity Wealth Advisors
California
$2.67M +$149K +1,306 +6%
TAM
1145
Tealwood Asset Management
Minnesota
$2.67M +$2.82M +24,709 New
ACM
1146
AlphaCrest Capital Management
New York
$2.66M -$12.8M -111,978 -82%
CAM
1147
Covenant Asset Management
New Jersey
$2.65M -$31.3K -274 -1%
SSI
1148
Scott & Selber Inc
Texas
$2.65M +$587K +5,135 +26%
AWM
1149
Apollon Wealth Management
South Carolina
$2.65M +$1.16M +10,118 +70%
CC
1150
Colrain Capital
Massachusetts
$2.65M +$343K +3,000 +14%
44 45
46
47 48

ABBV Hedge Fund Activity: Q3 2021 in Review

2,655 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2021, worth a combined $127B — down 4.6% from $133B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new ABBV positions and 97 closed out — a net gain of 20 holders — while 1,346 added to existing stakes and 872 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.02B. The largest seller was Fidelity Investments, cutting an estimated $1.58B.

  • 2,655 institutional investors held AbbVie (ABBV) as of Q3 2021, down from 2,677 in Q2 2021.
  • Funds reported $127B of AbbVie stock for Q3 2021, down 4.6% quarter-over-quarter.
  • 117 funds opened new AbbVie positions in Q3 2021 and 97 closed out, a net change of +20 holders.
  • The largest AbbVie buyer in Q3 2021 was JP Morgan Chase, an estimated $1.02B added.
  • The largest AbbVie seller in Q3 2021 was Fidelity Investments, an estimated $1.58B sold.

Based on aggregated 13F filings for Q3 2021.